| name | Ciclopirox Olamine |
| Classification | Antifungal |
| Pharmacokinetics | Ciclopirox olamine is primarily absorbed through the skin, with limited systemic absorption. The drug is metabolized in the liver and excreted through the kidneys. The extent of systemic absorption can vary, but is generally low. Concentrations in plasma are low and generally not significant. |
| suggested dosage | Ciclopirox olamine is typically applied topically, and dosage depends on the specific condition and formulation. Consult a dermatologist for appropriate recommendations. Generally, topical applications include a thin layer once or twice daily to affected areas. Exact dosages will depend on the strength of the formulation (i.e. 0.5% cream). |
| indications | Ciclopirox olamine is primarily used for the treatment of superficial fungal infections, particularly tinea infections (athlete's foot, ringworm, etc.) and seborrheic dermatitis. It can also be used to treat some types of dandruff. |
| safety in pregnancy | Limited data exist regarding the use of ciclopirox olamine in pregnant women. Although it is not typically considered to pose a significant risk to the developing fetus, caution is recommended. If used during pregnancy, the decision should be made in consultation with a physician to weigh potential benefits against potential risks. |
| safety in breastfeeding | Ciclopirox olamine is generally considered safe for use during breastfeeding in limited applications. However, as with other topical medications, it's essential to consult with a healthcare provider to ensure that the benefits outweigh the potential risks. Low concentrations are unlikely to reach the bloodstream in a meaningful amount. |
| side effects | Common side effects of topical ciclopirox olamine include skin irritation, such as redness, itching, burning, and dryness. Less common side effects can include allergic reactions, although these are uncommon. If severe or persistent side effects occur, discontinue use and seek medical attention. |
| alternatives | |
| contraindications | Ciclopirox olamine is generally well-tolerated. However, individuals with known allergies to ciclopirox olamine or related compounds should avoid its use. If there are open wounds or skin lesions in the area of application, the medication should be used with caution and appropriate consultation. |
| interactions | Limited interaction data exists for topical ciclopirox olamine. However, individuals with other conditions or who are taking other medications should inform their physician for potential interactions. There are no known significant drug interactions. |
| warnings and precautions | Ciclopirox olamine should be applied only to the affected areas and not to healthy skin. Avoid contact with eyes, and if contact occurs, rinse thoroughly with water. Do not use on broken or inflamed skin. If symptoms worsen or persist despite treatment, consult a healthcare professional. |
| additional informations | Proper hygiene is important when using ciclopirox olamine, to reduce the risk of reinfection. The topical application will not have significant impact on a systemic level for a male aged 25, weighing 70kg. This information is for educational purposes only and does not constitute medical advice. Always consult with a healthcare professional for any health concerns or before starting any new treatment. |
| patient details | |
